{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:30Z","timestamp":1786991250306,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jad.2019.02.024","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T20:51:24Z","timestamp":1549745484000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review"],"prefix":"10.1016","volume":"249","author":[{"given":"A.","family":"Amerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5657-9774","authenticated-orcid":false,"given":"A.","family":"Odone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.02.024_bib0001","article-title":"Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder","volume":"31","author":"Amerio","year":"2018","journal-title":"Gen. Psychiatr."},{"key":"10.1016\/j.jad.2019.02.024_bib0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review","volume":"166","author":"Amerio","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.02.024_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2015.06.005","article-title":"The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"186","author":"Amerio","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.02.024_bib0004","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/0004867417721653","article-title":"The Osler's view: treating comorbid bipolar disorder and obsessive-compulsive disorder","volume":"51","author":"Amerio","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.024_bib0005","first-page":"307","article-title":"Heredity in comorbid bipolar disorder and obsessive-compulsive disorder patients","volume":"27","author":"Amerio","year":"2015","journal-title":"Shanghai Arch Psychiatry"},{"key":"10.1016\/j.jad.2019.02.024_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajp.2016.01.009","article-title":"Course of illness in comorbid bipolar disorder and obsessive-compulsive disorder patients","volume":"20","author":"Amerio","year":"2016","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2019.02.024_bib0007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00131746-200507000-00004","article-title":"Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients","volume":"11","author":"Centorrino","year":"2005","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2019.02.024_bib0008","first-page":"18","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.02.024_bib0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.jad.2019.02.024_bib0010","unstructured":"Higgins, J. & Green, S. 2011. Cochrane handbook for systematic reviews of interventions, version 5.1.0.: The Cochrane Collaboration."},{"key":"10.1016\/j.jad.2019.02.024_bib0011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/NDT.S122316","article-title":"Aripiprazole augmentation in managing comorbid obsessive-compulsive disorder and bipolar disorder: a case with suicidal attempts","volume":"13","author":"Lai","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.02.024_bib0012","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2019.02.024_bib0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2015.11.033","article-title":"A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies","volume":"191","author":"Meduri","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.02.024_bib0014","series-title":"Trait\u00e9 Des Maladies Mentales","author":"Morel","year":"1860"},{"key":"10.1016\/j.jad.2019.02.024_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0004867416656262","article-title":"Treat the disease not the symptoms: successful management of obsessive compulsive disorder in bipolar disorder with aripiprazole augmentation","volume":"50","author":"Patra","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.024_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2018.03.014","article-title":"Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial","volume":"84","author":"Sahraian","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.024_bib0017","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0004867415621395","article-title":"Comorbid bipolar disorder and obsessive-compulsive disorder: which came first","volume":"50","author":"Tonna","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.024_bib0018","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.genhosppsych.2010.07.004","article-title":"Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder","volume":"32","author":"Uguz","year":"2010","journal-title":"Gen. Hosp. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718329161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718329161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:51:39Z","timestamp":1553727099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718329161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":18,"alternative-id":["S0165032718329161"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.02.024","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}